z-logo
open-access-imgOpen Access
Binding of a Soluble meso-Tetraarylporphyrin to Human Galectin-7 Induces Oligomerization and Modulates Its Pro-Apoptotic Activity
Author(s) -
Yossef López de los Santos,
David Bernard,
Philippe Egesborg,
Myriam Létourneau,
Clara Lafortune,
M.J. Cuneo,
Agathe Urvoas,
David Chatenet,
JeanPierre Mahy,
Yves StPierre,
Rémy Ricoux,
Nicolas Doucet
Publication year - 2020
Publication title -
biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.43
H-Index - 253
eISSN - 1520-4995
pISSN - 0006-2960
DOI - 10.1021/acs.biochem.0c00736
Subject(s) - jurkat cells , galectin , apoptosis , microbiology and biotechnology , galectin 3 , cell , cancer cell , galectin 1 , function (biology) , chemistry , plasma protein binding , biology , biochemistry , cancer , t cell , immunology , genetics , immune system
The selective targeting of protein-protein interactions remains a significant determinant for the proper modulation and regulation of cell apoptosis. Prototypic galectins such as human galectin-7 (GAL-7) are characterized by their ability to form homodimers that control the molecular fate of a cell by mediating subtle yet critical glycan-dependent interactions between pro- and anti-apoptotic molecular partners. Altering the structural architecture of GAL-7 can therefore result in resistance to apoptosis in various human cancer cells, further illustrating its importance in cell survival. In this study, we used a combination of biophysical and cellular assays to illustrate that binding of a water-soluble meso -tetraarylporphyrin molecule to GAL-7 induces protein oligomerization and modulation of GAL-7-induced apoptosis in human Jurkat T cells. Our results suggest that the integrity of the GAL-7 homodimer architecture is essential for its molecular function, in addition to providing an interesting porphyrin binding modulator for controlling apoptosis in mammalian cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here